The future of coronary artery radiation therapy - "The CART before the (unbridled) horse!"

Brachytherapy

Volumn 2, Issue 2, 2003, Pages 73-74

  Devlin, Philip M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; BRACHYTHERAPY; CORONARY ARTERY; CORONARY STENT; FOLLOW UP; HUMAN; PRIORITY JOURNAL; RESTENOSIS; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0042061290     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-4721(03)00103-X     Document Type: Article

References (9)

1. Regar E., Serruys P.W. The Ravel trial. Zero percent restenosis: a cardiologist's dream come true! Rev Esp Cardiol. 55:2002;459-462.
2. Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. J Am Coll Cardiol. 412:2003;184-189.
3. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of ISR. Circulation. 107:2003;24-27.
4. Tanabe K., Serruys P.W., Grube E., et al. Taxus III trial. Circulation. 107:2003;559-564.
5. Greenberg D., Cohen D.J. Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stent. Z Kardiol. 91:(Suppl 3):2002;137-143.
6. Personal communications with industrial leaders.
7. Wall Street Journal Analysis, 2003.
8. Personal communication Peter C. Levendag, MD.
9. Waksman R., Laird J.R., Jurkovitz C.T., et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol. 12:2001;915-921.